CURRENT LOCATION:
HOME》Technology transfer》Chemical technology transfer》New transfer》Fosaprepitant dimeglumine dimethyl
Fosaprepitant dimeglumine dimethyl
Project Name:Fosaprepitant dimeglumine dimethyl
Registration Classification:3.1
Formulations and specifications :Lyophilized: 115mg
Indications:This product used in combination with other antiemetics is suitable for controlling medium and large doses emetic anticancer chemotherapy ( including high-dose cisplatin ) and post- acute and repeated later than the initial medication caused nausea and vomiting.
Original Research Company:Merck
Progress :Pharmaceutical Research in progress